---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-003526"
form_type: "8-K"
ticker: "LUCD"
cik: "0001799011"
company_name: "Lucid Diagnostics Inc."
filed_at: "2025-04-10T23:59:59+00:00"
generated_at: "2026-05-23T17:23:40.469452+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lucid Diagnostics prices $15M public offering of 12.5M shares at $1.20 per share

## Summary
- Gross proceeds ~$15M from 12.5M shares at $1.20; underwriters have 45-day option for 1.875M additional shares.
- Closing expected April 11, 2025; net proceeds for working capital and general corporate purposes.
- Canaccord Genuity sole bookrunner, Maxim Group co-manager; offered under shelf registration effective Dec 2022.
- Offering significantly dilutes existing shareholders; exact dilution depends on option exercise.

## SEC filing metadata
- accession: 0001641172-25-003526
- form_type: 8-K
- ticker: LUCD
- cik: 0001799011
- company_name: Lucid Diagnostics Inc.
- filed_at: 2025-04-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799011/000164117225003526/0001641172-25-003526-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799011/000164117225003526/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-003526
- JSON: https://secwatch.observer/filing/0001641172-25-003526.json
- Plain text: https://secwatch.observer/filing/0001641172-25-003526.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.